Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134556) titled 'Application of Tegileridine PCIA combined with Liposomal Bupivacaine TAP for multimodal analgesia after colorectal cancer surgery in older patients' on Oct. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Nanning People's Hospital
Condition:
Acute pain after surgery
Intervention:
Tegileridine Group:Tagilildine was used for PCIA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-19
Target Sample Size: Tegileridine Group:48;Sufentanil group:48;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj....